Sleep disorders are highly prevalent among individuals with multiple sclerosis (MS), affecting nearly half of the patient population, according to study results presented at the European Committee for ...

A machine learning–based tool accurately predicted risk for recurrent inflammatory activity after DMT discontinuation in MS, highlighting its potential to guide personalized treatment decisions.

Patients with primary progressive MS more commonly exhibited delays in overall disability progression following treatment with ocrelizumab vs placebo.

Almost half of women with MS remain untreated during family planning, though ocrelizumab is the most commonly used DMT in this population.

The majority of infections in multiple sclerosis (MS) are reported in non-neurology practices, according to study results presented at the European Committee for Treatment and Research in Multiple ...

Elevated vitamin D levels may lower the risk for MS in White individuals, though this association is less pronounced in Black individuals.

Temperature sensitivity is associated with disease duration, dysautonomia, and quality of life in patients with multiple sclerosis.

Credit: Getty Images Researchers evaluated whether a deep learning model could distinguish between autoimmune neuroinflammatory disorders based on retinal thickness. A deep learning model, using optic ...

Compared with other measures of hypertension, the American Heart Association’s stage II hypertension category had the strongest association with disability worsening in patients with multiple ...

Credit: Getty Images Researchers identified clinical and magnetic resonance imagining predictors of fatigue worsening in patients with multiple sclerosis. Worsening fatigue in patients with multiple ...